.@CDCgov ACIP Recommendations for Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults
CDC’s Advisory Committee on Immunization Practices released recommendations for 21-valent pneumococcal conjugate vaccine adults aged ≥19 years.
More: https://t.co/BZjm80SZtH
.@CAPublicHealth Launches “Facts Fight Fentanyl” Campaign Combat Overdoses & Save Lives
CA Dept. of Public Health (CDPH) launches “Facts Fight Fentanyl” campaign to provide education about the dangers of fentanyl and how naloxone can save lives
More: https://t.co/PLTtCcTNFB
.@US_FDA Proposes New Easy-to-Read Medication Guide for Patients
FDA is proposing to amend the current human prescription drug labeling regulations to require a new Medication Guide called “Patient Medication Information.”
More: https://t.co/E2ofenWJCB
CSHP CEO, Loriann De Martini, gave the keynote address at the Touro University - California 2023 commencement ceremony.
We look forward to the contributions these amazing graduates will make on the next step in their pharmacy journey!
#PharmacyEvolution#TUCCOP#DeanJimScott
.@CAPharmBoard Free CE: Inspection Expectations, Diversion Trends, Loss Prevention, Legal Updates, & CURES
When: Fri, 6/2/23 8 AM - 5 PM PDT
Space is limited, & pre-registration is required.
Awarded 6 hours of CE credit for attending the session.
More: https://t.co/etn2IYcTZ2
California’s New Tools and Resources of Substance Use Prevention, Treatment, and Recovery
California continues to tackle the fentanyl and opioid crisis through new tools and resources for substance use prevention, treatment, and recovery.
More: https://t.co/yCdXRnWK4u
.@Surgeon_General Advisory on Impact of Epidemic of Loneliness and Isolation in the U.S.
U.S. Surgeon General released a new Surgeon General Advisory to call attention to the public health crisis of loneliness, isolation, and lack of connection.
More: https://t.co/PeA5zLOrRZ
.@US_FDA & .@CDCgov Update COVID-19 Vaccine Recommendations
FDA amended emergency use authorizations to authorize only bivalent vaccines for all doses for ages 6 months & up. Following FDA, CDC released simplified COVID-19 vaccine recommendations.
More: https://t.co/ISL9lu4AhS
.@US_FDA Approves 1st Nonprescription Naloxone Nasal Spray
FDA has approved Narcan (naloxone hydrochloride) nasal spray for nonprescription over-the-counter (OTC) use. Naloxone reverses the effects of opioid overdose & is a life-saving medication.
More: https://t.co/8j738DcfNc
.@NABP on Navigating Drug Shortages
The National Association of Boards of Pharmacy (NABP) released guidance for pharmacists to help their patients find safe alternative sources while dealing with drug shortages.
More: https://t.co/fmWfuTjpHc
Join us at the 2023 Pacific Coast Patient Safety Conference LIVE and hear from speaker, Dr. Elizabeth Rebo, Executive Director and Pharmacy Quality & Medication Safety from Kaiser Permanente!
Learn more & register ➡️ https://t.co/PhVHA1sjIn
Join us at the 2023 Pacific Coast Patient Safety Conference LIVE and hear from speaker, Dr. Elizabeth Rebo, Executive Director and Pharmacy Quality & Medication Safety from Kaiser Permanente!
Learn more & register ➡️ https://t.co/PhVHA1sjIn
CSHP 2022 President, Dr. Jim Scott, attended the ASHP State Affiliate Presidents Dinner at the Midyear Clinical Meeting 2022 in Las Vegas, NV.
We are thankful for the opportunity to meet and connect with so many great leaders from across the country! #PharmacyEvolution
We are proud to highlight Dr. Amy Kang for receiving a grant from the American College of Clinical Pharmacy for her research topic “Assessment of Antibiotic Transition Errors from Hospitals to Skilled Nursing Facilities.”
Read the full announcement: https://t.co/vZIcTWeS6V
@CSHP_Official and @ChapmanU are looking for speakers at the 2023 Pacific Coast Patient Safety Conference! Fill out the interest form to get started👇
https://t.co/FDtPgkdrkA